Loading...
032. Moxifloxacin pharmacokinetics in patients with lung infection from non-tuberculous mycobacteria
BACKGROUND: Lung infection from non-tuberculous mycobacteria (NTM), represent a significant clinical problem due to its increased incidence and difficult management. Moxifloxacin (MXF) can play an important role in the treatment of these infections, especially when microbial resistance is an issue....
Na minha lista:
| Udgivet i: | J Thorac Dis |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4332104/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.AB032 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|